SEC Comment Letter 0000000000-24-005779 to Century Therapeutics, Inc. (IPSC) (CIK 0001850119) (IPSC)
Century Therapeutics, Inc. (IPSC) (CIK 0001850119)
Date: May 17, 2024 · CIK: 0001850119 · Accession: 0000000000-24-005779
AI Filing Summary & Sentiment
File numbers found in text: 333-279422
Letter
United States securities and exchange commission logo May 17, 2024 Brent Pfeiffenberger Chief Executive Officer Century Therapeutics, Inc. 25 North 38th Street, 11th Floor Philadelphia, PA 19104 Re:Century Therapeutics, Inc. Registration Statement on Form S-3 Filed May 15, 2024 File No. 333-279422 Dear Brent Pfeiffenberger: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Justin S. Platt, Esq.
Show Raw Text
United States securities and exchange commission logo
May 17, 2024
Brent Pfeiffenberger
Chief Executive Officer
Century Therapeutics, Inc.
25 North 38th Street, 11th Floor
Philadelphia, PA 19104
Re:Century Therapeutics, Inc.
Registration Statement on Form S-3
Filed May 15, 2024
File No. 333-279422
Dear Brent Pfeiffenberger:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Justin S. Platt, Esq.